| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| Alda 1 |
N-(1,3-苯并二氧雜環(huán)戊烯-5-基甲基)-2,6-二氯苯甲酰胺 |
349438-38-6 |
詳細(xì)
|
| Alpelisib - NVP-BYL719 | BYL-719 |
阿培利司 |
1217486-61-7 |
詳細(xì)
|
| Amcasertib - BBI503 |
AMCASERTIB |
1129403-56-0 |
詳細(xì)
|
| AMG 232 |
2-((3R,5R,6S)-5-(3-氯苯基)-6-(4-氯苯基)-1-((S)-1-(異丙基磺酰基)-3-甲基丁烷-2-基)-3-甲基-2-氧代哌啶-3-基)乙酸 |
1352066-68-2 |
詳細(xì)
|
| AMG 900 |
AMG 900 |
945595-80-2 |
詳細(xì)
|
| AMI-1 - AMI-1 sodium salt |
猩紅酸鈉鹽 |
20324-87-2 |
詳細(xì)
|
| Aminoacridone, 2- |
2-氨基吖啶酮 |
27918-14-5 |
詳細(xì)
|
| Aminobenzamide, 3- - AB, 3- | ABA, 3- |
3-氨基苯甲酰胺 |
3544-24-9 |
詳細(xì)
|
| Aminotetraline hydrobromide, 6,7-Dimethoxy-2- |
|
40069-26-9 |
詳細(xì)
|
| Aminotetraline hydrobromide, N-Cyclopropyl-N-methyl-2- - CMAT |
|
1246094-80-3 |
詳細(xì)
|
| Aminotetraline hydrochloride, (R)-(+)-7-Methoxy-N-propyl-2- |
(R)-7-甲氧基-N-丙基-1,2,3,4-四氫萘-2-胺鹽酸鹽 |
93503-08-3 |
詳細(xì)
|
| 10058-F4 |
5-(4-乙基苯亞甲基)繞丹寧 (該產(chǎn)品不可在美國(guó)銷(xiāo)售) |
403811-55-2 |
詳細(xì)
|
| 15-LOX-1 inhibitor i472 |
|
|
詳細(xì)
|
| 3-Chloro-4-(pyridin-3-yl)-1,2,5-thiadiazole |
3-氯-4-(吡啶-3-基)-1,2,5-噻二唑 |
131986-28-2 |
詳細(xì)
|
| 3PO |
3PO |
18550-98-6 |
詳細(xì)
|
| 4μ8C |
4Μ8C |
14003-96-4 |
詳細(xì)
|
| 6,8-Bis(benzylthio)octanoic acid |
6,8-雙(芐硫基)辛酸 |
95809-78-2 |
詳細(xì)
|
| A 1070722 |
1-(7-Methoxyquinolin-4-yl)-3-[6-(trifluoromethyl)pyridin-2-yl]urea |
1384424-80-9 |
詳細(xì)
|
| A 357300 hydrochloride |
化合物 A-357300 |
369358-07-6 |
詳細(xì)
|
| A 66 |
A66 |
1166227-08-2 |
詳細(xì)
|
| A 769662 |
4-羥基-3-(2'-羥基-1,1'-聯(lián)苯-4-基)-6-氧代-6,7-二氫噻吩并[2,3-B]吡啶-5-甲腈 |
844499-71-4 |
詳細(xì)
|
| A 770041 |
A-770041 |
869748-10-7 |
詳細(xì)
|
| A 922500 |
DGAT-1 抑制劑 |
959122-11-3 |
詳細(xì)
|
| A-196 |
1982372-88-2 |
1982372-88-2 |
詳細(xì)
|
| A-92 |
1448693-69-3 |
1448693-69-3 |
詳細(xì)
|
| Abiraterone - CB 7598 |
阿比特龍 |
154229-19-3 |
詳細(xì)
|
| Abiraterone acetate - CB 7630 | JNJ 212082 |
乙酸阿比特龍酯 |
154229-18-2 |
詳細(xì)
|
| ABT 702 |
5-(3-溴苯基)-7-[6-(4-嗎啉基)-3-吡啶基]-吡啶并[2,3-D]嘧啶-4-胺 |
214697-26-4 |
詳細(xì)
|
| ABT 888 - Veliparib | A 861695 |
維利帕尼 |
912444-00-9 |
詳細(xì)
|
| ABT 888 dihydrochloride - Veliparib dihydrochloride | A 861695 dihydrochloride |
維利帕尼鹽酸鹽 |
912445-05-7 |
詳細(xì)
|
| Acalisib - GS 9820 | CAL 120 |
GS-9820 |
870281-34-8 |
詳細(xì)
|
| ADAMTS-5 inhibitor - Compound 12 |
ADAMTS-5 |
929634-33-3 |
詳細(xì)
|
| AEG 3482 |
6-苯基咪唑并[2,1-B]-1,3,4-噻二唑-2-磺酰胺 |
63735-71-7 |
詳細(xì)
|
| AG 014699 - PF 01367338 | Rucaparib |
瑞卡帕布（AG-014699） |
459868-92-9 |
詳細(xì)
|
| AG 490 - Tyrphostin AG 490 | Tyrphostin B42 |
酪氨酸磷酸化抑制劑AG 490 |
133550-30-8 |
詳細(xì)
|
| AG 7088 - Rupintrivir | Ruprintrivir |
(2E,4S)-4-[(2R,5S)-2-(4-氟芐基)-6-甲基-5-(5-甲基異惡唑-3-基甲酰氨基)-4-氧代庚酰氨基]-5-[[(3S)-2-氧代-3-吡咯烷基]-2-戊烯酸乙酯 |
223537-30-2 |
詳細(xì)
|
| AG-120 - Ivosidenib |
艾伏尼布 |
1448347-49-6 |
詳細(xì)
|
| AG-221 - Enasidenib |
恩西地平 |
1446502-11-9 |
詳細(xì)
|
| AGI 5198 - IDH-C35 |
AGI-5198 (IDH-C35) |
1355326-35-0 |
詳細(xì)
|
| AGI 6780 |
AGI-6780 |
1432660-47-3 |
詳細(xì)
|
| AICAR - Acadesine | NSC 105823 | AICA-riboside | Arasine |
阿卡地新 |
2627-69-2 |
詳細(xì)
|
| AZD 1208 |
AZD1208 |
1204144-28-4 |
詳細(xì)
|
| AZD 2281 - Olaparib | KU 0059436 |
奧拉帕尼 |
763113-22-0 |
詳細(xì)
|
| AZD 2461 |
4-[4-氟-3-[(4-甲氧基哌啶-1-基)羰基]芐基]酞嗪-1(2H)-酮 |
1174043-16-3 |
詳細(xì)
|
| AIM 100 |
5,6-二苯基-N-[[(2S)-四氫-2-呋喃基]甲基]呋喃并[2,3-D]嘧啶-4-胺 |
873305-35-2 |
詳細(xì)
|
| AZD 1152-HQPA |
5-[[7-[3-[乙基(2-羥基乙基)氨基]丙氧基]-4-喹唑啉]氨基]-N-(3-氟苯基)-1H-吡唑-3-乙酰胺 |
722544-51-6 |
詳細(xì)
|
| Aminotetraline hydrochloride, (R)-8-Methoxy-N-propyl-2- |
(R)-8-甲氧基-N-丙基-1,2,3,4-四氫萘-2-胺鹽酸鹽 |
78095-32-6 |
詳細(xì)
|
| Aminotetraline hydrochloride, (S)-(-)-7-Methoxy-N-propyl-2- |
(S)-7-甲氧基-N-丙基-1,2,3,4-四氫萘-2-胺鹽酸鹽 |
93503-09-4 |
詳細(xì)
|
| Aminotetraline hydrochloride, (S)-6-Methoxy-2- - Tetrahydro-6-methoxy-2-naphthalenamine hydrochloride, (2S)-1,2,3,4- |
(S)-6-methoxy-2-aminotetralin hydrochloride |
1229244-88-5 |
詳細(xì)
|
| Aminotetraline hydrochloride, (S)-7-Methoxy-2- - (S)-7-MeO-DPAT hydrochloride |
(S)-7-甲氧基-2-氨基四氫化萘鹽酸鹽 |
158223-16-6 |
詳細(xì)
|
| Aminotetraline hydrochloride, (S)-8-Methoxy-N-propyl-2- |
(S)-8-甲氧基-N-丙基-1,2,3,4-四氫萘-2-胺鹽酸鹽 |
78095-35-9 |
詳細(xì)
|
| Aminotetraline hydrochloride, 5-Methoxy-N-propyl-2- |
(5-甲氧基-1,2,3,4-四氫萘-2-基)丙胺鹽酸鹽 |
3904-24-3 |
詳細(xì)
|
| Amuvatinib - MP 470 |
N-(1,3-苯并二氧戊環(huán)-5-基甲基)-4-苯并呋喃并[3,2-D]嘧啶-4-基-1-哌嗪硫代甲酰胺 |
850879-09-3 |
詳細(xì)
|
| Anacardic acid A - Pentadecylsalicylic acid, 6- |
漆樹(shù)酸 |
16611-84-0 |
詳細(xì)
|
| AP 24534 - Ponatinib |
帕納替尼 |
943319-70-8 |
詳細(xì)
|
| APC, 4- - VUF 11000 |
2-(4-氨基苯氧基)-N,N,N-三甲基乙基溴化氫溴酸 |
1076196-38-7 |
詳細(xì)
|
| APE1 Inhibitor III |
化合物 APE1-IN-1 |
524708-03-0 |
詳細(xì)
|
| APEBA, 4- - VUF 10996 |
|
1226984-28-6 |
詳細(xì)
|
| Apixaban - BMS 562247-01 |
阿哌沙班 |
503612-47-3 |
詳細(xì)
|
| Apoptosis Activator 2 |
1-(3,4-二氯芐基)-1H-吲哚-2,3-二酮 |
79183-19-0 |
詳細(xì)
|
| Apoptozole |
BenzaMide, 4-[[2-[3,5-bis(trifluoroMethyl)phenyl]-4,5-bis(4-Methoxyphenyl)-1H-iMidazol-1-yl]Methyl]- |
1054543-47-3 |
詳細(xì)
|
| APPA |
N-乙?；?3-乙酰氧基-5-苯基吡咯 |
100750-39-8 |
詳細(xì)
|
| Apremilast - CC 10004 |
阿普斯特 |
608141-41-9 |
詳細(xì)
|
| APS-2-79 |
APS-2-79 鹽酸鹽 |
2002381-31-7 |
詳細(xì)
|
| AR03 |
Benzo[b][1,8]naphthyridin-5-amine, 2,4,9-trimethyl- (9CI) |
510721-85-4 |
詳細(xì)
|
| AR-42 |
AR-42 |
935881-37-1 |
詳細(xì)
|
| AR-A 014418 |
AR-A 014418 |
487021-52-3 |
詳細(xì)
|
| ARM1 hydrobromide |
ARM1 hydrobromide |
1049743-03-4 |
詳細(xì)
|
| ARN 272 |
ARN272 |
488793-85-7 |
詳細(xì)
|
| AS 1517499 |
AS1517499 |
919486-40-1 |
詳細(xì)
|
| AS 1842856 |
5-氨基-7-(環(huán)己基氨基)-1-乙基-6-氟-1,4-二氫-4-氧代-3-喹啉羧酸 |
836620-48-5 |
詳細(xì)
|
| AS 1892802 |
AS 1892802 |
928320-12-1 |
詳細(xì)
|
| AS 252424 |
5-[[5-(4-氟-2-羥基苯基)-2-呋喃基]亞甲基]-2,4-噻唑烷二酮 |
900515-16-4 |
詳細(xì)
|
| AS 252424 bispotassium salt - AS 252424K |
|
|
詳細(xì)
|
| AS 602801 - Bentamapimod |
本塔馬莫 |
848344-36-5 |
詳細(xì)
|
| ASB14780 |
ASB14780 |
1069046-00-9 |
詳細(xì)
|
| ASK1 Inhibitor 10 |
化合物 T13099 |
1005775-56-3 |
詳細(xì)
|
| ASP 3026 |
ASP3026 |
1097917-15-1 |
詳細(xì)
|
| ASP 9521 |
1-[1-[(5-甲氧基-1H-吲哚-2-基)羰基]哌啶-4-基]-2-甲基丙-2-醇 |
1126084-37-4 |
詳細(xì)
|
| AT 13148 dihydrochloride |
AT13148 |
1056901-62-2 |
詳細(xì)
|
| AT 7519 mesylate |
4-[(2,6-二氯苯甲?；?氨基]-N-4-哌啶基-1H-吡唑-3-甲酰胺甲磺酸鹽 |
902135-89-1 |
詳細(xì)
|
| AT 9283 |
AT9283 |
896466-04-9 |
詳細(xì)
|
| ATB 346 |
ATB 346 |
1226895-20-0 |
詳細(xì)
|
| Atglistatin |
ATGLISTATIN |
1469924-27-3 |
詳細(xì)
|
| Aurora A inhibitor I |
Aurora A Inhibitor I |
1158838-45-9 |
詳細(xì)
|
| Aurora A inhibitor II |
|
1158838-43-7 |
詳細(xì)
|
| Autophinib |
6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE |
1644443-47-9 |
詳細(xì)
|
| AVL 292 - CC 292 |
AVL292 |
1202757-89-8 |
詳細(xì)
|
| AZ 20 |
AZ20 |
1233339-22-4 |
詳細(xì)
|
| AZ 3146 |
AZ3146 |
1124329-14-1 |
詳細(xì)
|
| AZ 628 |
AZ 628 |
878739-06-1 |
詳細(xì)
|
| AZ 960 |
5-氟-2-[[(1S)-1-(4-氟苯基)乙基]氨基]-6-[(5-甲基-1H-吡唑-3-基)氨基]-3-吡啶腈 |
905586-69-8 |
詳細(xì)
|
| AZ13705339 |
化合物 T26704 |
2016806-57-6 |
詳細(xì)
|
| AZD 0530 difumarate - Saracatinib |
4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2) |
893428-72-3 |
詳細(xì)
|
| AZD 1080 |
AZD1080 |
612487-72-6 |
詳細(xì)
|
| Aminotetraline hydrochloride, (R)-6-Methoxy-2- - Tetrahydro-6-methoxy-2-naphthalenamine hydrochloride, (2R)-1,2,3,4- |
(R)-6-Methoxy-2-aminotetralin hydrochloride |
1229244-90-9 |
詳細(xì)
|
| AK 1 |
SIRT2 Inhibitor II, AK-1 |
330461-64-8 |
詳細(xì)
|
| AK 7 |
N-(3-溴苯基)-3-[(六氫-1H-氮雜卓-1-基)磺?；鵠-苯甲酰胺 |
420831-40-9 |
詳細(xì)
|
| Akt Inhibitor VIII - Akti-1/2 |
1,3-二氫-1-[1-[[4-(6-苯基-1H-咪唑并[4,5-G]喹喔啉-7-基)苯基]甲基]-4-哌啶基]-2H-苯并咪唑-2-酮 |
612847-09-3 |
詳細(xì)
|